SeekingAlpha · Oct 15, 2026
Demant A/S (WILYY) Presents at EUHA 2026 -- International Congress of Hearing Aid Acousticians - Slideshow
2026-10-15. The following slide deck was published by Demant A/S in conjunction with this event.
WI
OTC · WILYY
Demant A/S
Healthcare · Medical - Devices
$27.25
Up+$0.00 (+0.00%)
Updated Nov 3, 2026, 3:43 PM
SID Score
5.7/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 7.03B
- P/E ratio
- 20.04
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 0
- Avg. volume
- 60
Price performance · WILYY
WILYY price history
1M range · 0 trading sessions · Daily adjusted prices
WILYY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest WILYY news
The latest Smart Investors Daily articles mentioning WILYY.
Stock researchCompany · Overview
Company
Market Activity
Research & News
WILYY research
Overview
Company profile and research snapshot.
Company profile
DEMANT HLDG U/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $21.34
- Implied upside
- —
- Analysts
- 24
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 23, 2026 | JEFFERIES | Buy | — |
| Sep 23, 2026 | JYSKE BANK | Hold | — |
| Aug 31, 2026 | BNP PARIBAS | Neutral | — |
| Aug 21, 2026 | EQUITA SIM | Hold | — |
| Aug 12, 2026 | DNB CARNEGIE | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 13, 2026
Demant (CPSE:DEMANT) Wins On Oticon Reveal, Is The Valuation Already Full?
Demant (CPSE:DEMANT) is in focus after its new Oticon Reveal hearing aid was well received, prompting higher growth and earnings forecasts and reflecting firm demand from the key US hearing care market. Recent trading reflects that enthusiasm. Demant’s share price has climbed strongly, with a 21.06% 1 month share price return and a 27.74% 3 month share price return. This has contributed to a 67.01% year to date share price gain and a 58.97% 1 year total shareholder return that points to...
Yahoo · Sep 25, 2026
Bernstein unveils top European medtech stock picks to buy for H2
Investing.com -- European medtech has had another bruising year, with only Demant and Sonova outperforming the Stoxx 600 in 2026 as the sector’s once-premium valuation continues to de-rate.
SeekingAlpha · Aug 12, 2026
Demant A/S (WILYY) Q2 2026 Earnings Call Transcript
Demant A/S (WILYY) Q2 2026 Earnings Call August 12, 2026 8:00 AM EDTCompany ParticipantsPeter Pudselykke - Head of Investor Relations (Leave of...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
